Yes. EICBPI 2027 is an open international conference. Researchers, academics, professionals, students, clinicians, innovators and industry participants are welcome.
Delegate Information Open international conference
EICBPI 2027 is an open international conference for researchers, academics, students, biotechnology and pharmaceutical scientists, clinicians, professionals, innovators, manufacturers and industry participants. Industry leaders and selected academicians are welcome — but all participants must follow the same pathway: submit a abstract or request an invitation. Non-presenting delegates may register directly. Presenters should submit an abstract, receive a review decision, and then register to confirm their presentation.
Choose the pathway that matches how you plan to participate.
If you have not received acceptance or confirmation, do not attempt to register. Use the abstract or invitation request forms first.
Essential questions (clear answers)
We have included only the necessary items to avoid confusion. For anything else, email participation@executivecongresses.com.
Yes. Non-presenting delegates may register directly. Presenters should submit an abstract and register after acceptance to confirm their presentation.
EICBPI 2027 welcomes researchers, academics, students, biotechnology scientists, pharmaceutical researchers, clinicians, R&D professionals, innovation teams, regulatory specialists, manufacturing professionals, investors, and industry participants working across research, translation, development, manufacturing, and real-world application.
Yes. Non-presenting delegates may register directly without submitting an abstract and can attend keynote sessions, oral and poster presentations, panels and networking activities.
Use the Submit Abstract page and provide the required author details, presentation title and abstract. Submissions are reviewed for relevance, clarity, quality and alignment with the conference themes.
Yes. We welcome selected academicians whose work aligns with biotechnology innovation, pharmaceutical translation, regulation, manufacturing readiness, or strategic collaboration. However, academicians are not exempt from curation — participation is still open and requires abstract acceptance or invitation confirmation.
Yes. Approved participants may attend without presenting as strategic delegates, investors, industry partners, or academic observers. Attendance without speaking is still subject to invitation or acceptance.
You will receive a review decision by email. If accepted, you will receive presentation and registration guidance. Non-presenting delegates may proceed directly to registration.
Not every abstract can be scheduled. Decisions depend on scope, quality, relevance and programme capacity. Where relevant, we may suggest an alternative participation format, consider you for future editions, or invite you to partner sessions aligned with your profile.
Sponsors, exhibitors, institutions and partners may contact the conference team directly or use the Sponsor & Exhibition page, or email us with your objectives and preferred engagement.
Yes. After acceptance or confirmation, we can support invoices, participation confirmation, and documentation where required. Please email us with your billing details and internal requirements.
Visa letters are issued where applicable after acceptance or confirmation. Please refer to the Visa Letter page and contact us if you need documentation guidance.